MicroRNA-320a suppresses human colon cancer cell proliferation by directly targeting β-catenin

Biochemical and Biophysical Research Communications

Volumn 420, Issue 4, 2012, Pages 787-792

  Sun, Jian Yong ^a,b   Huang, Yi ^b   Li, Ji Peng ^b   Zhang, Xiang ^a   Wang, Lei ^a   Meng, Yan Ling ^a   Yan, Bo ^a   Bian, Yong Qian ^b   Zhao, Jing ^a   Wang, Wei Zhong ^b   Yang, An Gang ^a   Zhang, Rui ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Catenin; Colorectal cancer; MicroRNA; Proliferation

Indexed keywords

BETA CATENIN; MICRORNA; MICRORNA 320A; UNCLASSIFIED DRUG;

ARTICLE; BIOINFORMATICS; CANCER CELL; CANCER GROWTH; CANCER TISSUE; CELL CYCLE REGULATION; CELL PROLIFERATION; COLON CANCER; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN TARGETING; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR DOWN REGULATION;

BETA CATENIN; CELL LINE, TUMOR; CELL PROLIFERATION; COLONIC NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE TARGETING; HUMANS; MICRORNAS; TRANSCRIPTION, GENETIC;

EID: 84859812754     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.03.075     Document Type: Article

References (37)

1. Jemal A., Siegel R., Ward E., et al. Cancer statistics. CA Cancer J. Clin. 2007, 57(2007):43-66.
2. Wood L.D., Parsons D.W., Jones S., et al. The genomic lscapes of human breast and colorectal cancers. Science 2007, 318:1108-1113.
3. Bozic I., Antal T., Ohtsuki H., et al. Accumulation of driver passenger mutations during tumor progression. Proc. Natl. Acad. Sci. USA 2010, 107:18545-18550.
4. Carter H., Chen S., Isik L., et al. Cancer-specific high-throughput annotation of somatic mutations computational prediction of driver missense mutations. Cancer Res. 2009, 69:6660-6667.
5. Fearon E.R., Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990, 61:759-767.
6. Markowitz S.D., Bertagnolli M.M. Molecular origins of cancer: molecular basis of colorectal cancer. N. Engl. J. Med. 2009, 361:2449-2460.
7. Bartel D.P. MicroRNAs target recognition regulatory functions. Cell 2009, 136:215-233.
8. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism and function. Cell 2004, 116:281-297.
9. Garzon R., Calin G.A., Croce C.M. MicroRNAs in Cancer. Annu. Rev. Med. 2009, 60:167-179.
10. Schetter A.J., Leung S.Y., Sohn J.J., et al. MicroRNA expression profiles associated with prognosis therapeutic outcome in colon adenocarcinoma. JAMA 2008, 299:425-436.
11. Cummins J.M., He Y., Leary R.J., et al. The colorectal microRNAome. Proc. Natl. Acad. Sci. USA 2006, 103:3687-3692.
12. Schepeler T., Reinert J.T., Ostenfeld M.S., et al. Diagnostic and prognostic microRNAs in stage II colon cancer. Cancer Res. 2008, 68:6416-6424.
13. Thomas M., Lieberman J., Lal A. Desperately seeking microRNA targets. Nat. Struct. Mol. Biol. 2010, 17:1169-1174.
14. He T.C., Sparks A.B., Rago C., et al. Identification of c-MYC as a target of the APC pathway. Science 1998, 281:1509-1512.
15. Tetsu O., McCormick F. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 1999, 398:422-426.
16. Kim P.J., Plescia J., Clevers H., et al. Survivin and molecular pathogenesis of colorectal cancer. Lancet 2003, 362:205-209.
17. Meng F., Henson R., Lang M., et al. Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines. Gastroenterology 2006, 130:2113-2129.
18. Chen L., Yan H.X., Yang W., et al. The role of microRNA expression pattern in human intrahepatic cholangiocarcinoma. J. Hepatol. 2009, 50:358-369.
19. Calin G.A., Dumitru C.D., Shimizu M., et al. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc. Natl. Acad. Sci. USA 2002, 99:15524-15529.
20. Volinia S., Calin G.A., Liu C.G., et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc. Natl. Acad. Sci. USA 2006, 103:2257-2261.
21. Lu J., Getz G., Miska E.A., et al. MicroRNA expression profiles classify human cancers. Nature 2005, 435:834-838.
22. Garzon R., Marcucci G., Croce C.M. Targeting microRNAs in cancer rationale, strategies and challenges. Nat. Rev. Drug. Discov. 2010, 9:775-789.
23. Zhang H., Li W., Nan F., et al. MicroRNA expression profile of colon cancer stem-like cells in HT29 adenocarcinoma cell line. Biochem. Biophys. Res. Commun. 2011, 404:273-278.
24. Reya T., Clevers H. Wnt signalling in stem cells and cancer. Nature 2005, 434:843-850.
25. de Sousa E.M., Vermeulen L., Richel D., et al. Targeting Wnt signaling in colon cancer stem cells. Clin. Cancer Res. 2011, 17:647-653.
26. Kanwar S.S., Yu Y., Nautiyal J., et al. The Wnt/beta-catenin pathway regulates growth and maintenance of colonospheres. Mol. Cancer. 2010, 9:212.
27. Diakos C., Zhong S., Xiao Y., et al. TEL-AML1 regulation of survivin and apoptosis via miRNA-494 and miRNA-320a. Blood 2010, 116:4885-4893.
28. Bronisz A., Godlewski J., Wallace J.A., et al. Reprogramming of the tumour microenvironment by stromal PTEN-regulated miR-320. Nat. Cell Biol. 2011, 14:159-167.
29. Kota J., Chivukula R.R., O'Donnell K.A., et al. Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell 2009, 137:1005-1017.
30. Huse J.T., Brennan C., Hambardzumyan D., et al. The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo. Genes Dev. 2009, 23:1327-1337.
31. Y.Z. Deng, F. Yao, J.J. Li, et al. RACK1 Suppresses Gastric Tumorigenesis by Stabilizing the β-Catenin Destruction Complex, Gastroenterology. 2012.
32. Woo D.K., Kim H.S., Lee H.S., et al. Altered expression and mutation of beta-catenin gene in gastric carcinomas and cell lines. Int. J. Cancer. 2001, 95:108-113.
33. de La Coste A., Romagnolo B., Billuart P., et al. Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas. Proc. Natl. Acad. Sci. USA 1998, 95:8847-8851.
34. Yang G., Fu H., Zhang J., et al. RNA-binding protein quaking, a critical regulator of colon epithelial differentiation and a suppressor of colon cancer. Gastroenterology 2010, 138:231-240.
35. Xia H., Cheung W.K., Sze J., et al. MiR-200a regulates epithelial-mesenchymal to stem-like transition via ZEB2 and beta-catenin signaling. J. Biol. Chem. 2010, 285:36995-37004.
36. H. Hirata, Y. Hinoda, K. Ueno, et al. MicroRNA-1826 directly targets beta-catenin (CTNNB1) and MEK1 (MAP2K1) in VHL-inactivated renal cancer, Carcinogenesis. 2012 (Epub ahead of print).
37. Veronese A., Visone R., Consiglio J., et al. Mutated beta-catenin evades a microRNA-dependent regulatory loop. Proc. Natl. Acad. Sci. USA 2011, 108:4840-4845.